EW logo

EW Cash From Financing

Annual CFF:

-$983.00M-$272.00M(-38.26%)
December 31, 2024

Summary

  • As of today, EW annual cash from financing is -$983.00 million, with the most recent change of -$272.00 million (-38.26%) on December 31, 2024.
  • During the last 3 years, EW annual cash from financing has fallen by -$626.70 million (-175.89%).
  • EW annual cash from financing is now -2916.62% below its all-time high of $34.90 million, reached on December 31, 2013.

Performance

EW Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Quarterly CFF:

-$506.40M-$559.10M(-1060.91%)
September 30, 2025

Summary

  • As of today, EW quarterly cash from financing is -$506.40 million, with the most recent change of -$559.10 million (-1060.91%) on September 30, 2025.
  • Over the past year, EW quarterly cash from financing has increased by +$470.30 million (+48.15%).
  • EW quarterly cash from financing is now -499.37% below its all-time high of $126.80 million, reached on June 30, 2017.

Performance

EW Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

TTM CFF:

-$683.10M+$470.30M(+40.78%)
September 30, 2025

Summary

  • As of today, EW TTM cash from financing is -$683.10 million, with the most recent change of +$470.30 million (+40.78%) on September 30, 2025.
  • Over the past year, EW TTM cash from financing has increased by +$741.70 million (+52.06%).
  • EW TTM cash from financing is now -2057.31% below its all-time high of $34.90 million, reached on December 31, 2013.

Performance

EW TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

EW Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-38.3%+48.1%+52.1%
3Y3 Years-175.9%-624.5%+15.5%
5Y5 Years-750.4%-1589.4%-39.0%

EW Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-175.9%+38.0%-920.8%+48.1%-54.3%+56.9%
5Y5-Year-750.4%+38.0%-920.8%+48.1%-290.8%+56.9%
All-TimeAll-Time-2916.6%+38.0%-499.4%+48.1%-2057.3%+56.9%

EW Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$506.40M(-1060.9%)
-$683.10M(+40.8%)
Jun 2025
-
$52.70M(+120.4%)
-$1.15B(+11.5%)
Mar 2025
-
-$258.00M(-1002.1%)
-$1.30B(-32.5%)
Dec 2024
-$983.00M(-38.3%)
$28.60M(+102.9%)
-$983.00M(+31.0%)
Sep 2024
-
-$976.70M(-911.1%)
-$1.42B(-140.9%)
Jun 2024
-
-$96.60M(-256.6%)
-$591.40M(-33.6%)
Mar 2024
-
$61.70M(+114.9%)
-$442.70M(+37.7%)
Dec 2023
-$711.00M(+55.1%)
-$413.20M(-188.3%)
-$711.00M(+37.4%)
Sep 2023
-
-$143.30M(-375.0%)
-$1.14B(-6.9%)
Jun 2023
-
$52.10M(+125.2%)
-$1.06B(+25.3%)
Mar 2023
-
-$206.60M(+75.4%)
-$1.42B(+10.2%)
Dec 2022
-$1.58B(-344.7%)
-$838.40M(-1099.4%)
-$1.58B(-96.1%)
Sep 2022
-
-$69.90M(+77.3%)
-$808.10M(-15.6%)
Jun 2022
-
-$308.10M(+16.3%)
-$699.20M(-55.3%)
Mar 2022
-
-$368.10M(-493.7%)
-$450.10M(-26.3%)
Dec 2021
-$356.30M(+26.8%)
-$62.00M(-259.0%)
-$356.30M(-40.9%)
Sep 2021
-
$39.00M(+166.1%)
-$252.90M(+1.9%)
Jun 2021
-
-$59.00M(+78.5%)
-$257.90M(-47.5%)
Mar 2021
-
-$274.30M(-762.6%)
-$174.80M(+64.1%)
Dec 2020
-$486.90M(-321.2%)
$41.40M(+21.8%)
-$486.90M(+0.9%)
Sep 2020
-
$34.00M(+41.1%)
-$491.30M(-0.1%)
Jun 2020
-
$24.10M(+104.1%)
-$490.90M(+34.2%)
Mar 2020
-
-$586.40M(-1684.9%)
-$746.40M(-545.7%)
Dec 2019
-$115.60M(+89.5%)
$37.00M(+7.6%)
-$115.60M(+88.4%)
Sep 2019
-
$34.40M(+114.9%)
-$997.30M(+8.4%)
Jun 2019
-
-$231.40M(-621.2%)
-$1.09B(+0.8%)
Mar 2019
-
$44.40M(+105.3%)
-$1.10B(+0.3%)
Dec 2018
-$1.10B(-132.7%)
-$844.70M(-1389.8%)
-$1.10B(-126.8%)
Sep 2018
-
-$56.70M(+76.4%)
-$485.50M(-18.8%)
Jun 2018
-
-$240.70M(-688.5%)
-$408.50M(-896.3%)
Mar 2018
-
$40.90M(+117.9%)
-$41.00M(+91.3%)
Dec 2017
-$473.20M(-76.2%)
-$229.00M(-1228.1%)
-$473.20M(-97.9%)
Sep 2017
-
$20.30M(-84.0%)
-$239.10M(-22.2%)
Jun 2017
-
$126.80M(+132.4%)
-$195.60M(+32.7%)
Mar 2017
-
-$391.30M(-7772.5%)
-$290.70M(-8.3%)
Dec 2016
-$268.50M(-69.3%)
$5.10M(-92.0%)
-$268.50M(+19.4%)
Sep 2016
-
$63.80M(+101.3%)
-$333.30M(+10.8%)
Jun 2016
-
$31.70M(+108.6%)
-$373.50M(+18.1%)
Mar 2016
-
-$369.10M(-518.3%)
-$455.80M(-187.4%)
Dec 2015
-$158.60M(-3.7%)
-$59.70M(-353.0%)
-$158.60M(-199.2%)
Sep 2015
-
$23.60M(+146.6%)
-$53.00M(-90.0%)
Jun 2015
-
-$50.60M(+29.6%)
-$27.90M(+65.6%)
Mar 2015
-
-$71.90M(-256.6%)
-$81.10M(+47.0%)
Dec 2014
-$153.00M(-538.4%)
$45.90M(-5.7%)
-$153.00M(-29.2%)
Sep 2014
-
$48.70M(+146.9%)
-$118.40M(-20.2%)
Jun 2014
-
-$103.80M(+27.8%)
-$98.50M(-17.3%)
Mar 2014
-
-$143.80M(-278.6%)
-$84.00M(-340.7%)
Dec 2013
$34.90M(+122.4%)
$80.50M(+17.3%)
$34.90M(+118.1%)
Sep 2013
-
$68.60M(+176.8%)
-$192.50M(+26.4%)
Jun 2013
-
-$89.30M(-258.6%)
-$261.60M(-47.5%)
Mar 2013
-
-$24.90M(+83.0%)
-$177.40M(-14.0%)
Dec 2012
-$155.60M
-$146.90M(>-9900.0%)
-$155.60M(-47.2%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$500.00K(+90.2%)
-$105.70M(+42.6%)
Jun 2012
-
-$5.10M(-64.5%)
-$184.20M(+6.9%)
Mar 2012
-
-$3.10M(+96.8%)
-$197.80M(-46.3%)
Dec 2011
-$135.20M(-30.1%)
-$97.00M(-22.8%)
-$135.20M(-108.6%)
Sep 2011
-
-$79.00M(-322.5%)
-$64.80M(-52.8%)
Jun 2011
-
-$18.70M(-131.4%)
-$42.40M(-11.6%)
Mar 2011
-
$59.50M(+323.7%)
-$38.00M(+63.4%)
Dec 2010
-$103.90M(-13.2%)
-$26.60M(+53.0%)
-$103.90M(-41.6%)
Sep 2010
-
-$56.60M(-295.8%)
-$73.40M(-70.3%)
Jun 2010
-
-$14.30M(-123.4%)
-$43.10M(+2.7%)
Mar 2010
-
-$6.40M(-264.1%)
-$44.30M(+51.7%)
Dec 2009
-$91.80M(+31.5%)
$3.90M(+114.8%)
-$91.80M(+35.0%)
Sep 2009
-
-$26.30M(-69.7%)
-$141.30M(-31.1%)
Jun 2009
-
-$15.50M(+71.2%)
-$107.80M(-20.6%)
Mar 2009
-
-$53.90M(-18.2%)
-$89.40M(+33.3%)
Dec 2008
-$134.10M(-24.1%)
-$45.60M(-733.3%)
-$134.10M(-25.6%)
Sep 2008
-
$7.20M(+148.3%)
-$106.80M(+28.8%)
Jun 2008
-
$2.90M(+102.9%)
-$150.10M(+21.0%)
Mar 2008
-
-$98.60M(-438.8%)
-$189.90M(-75.7%)
Dec 2007
-$108.10M(+44.2%)
-$18.30M(+49.3%)
-$108.10M(+11.5%)
Sep 2007
-
-$36.10M(+2.2%)
-$122.10M(+16.8%)
Jun 2007
-
-$36.90M(-119.6%)
-$146.80M(+11.2%)
Mar 2007
-
-$16.80M(+48.0%)
-$165.40M(+14.6%)
Dec 2006
-$193.60M(-767.6%)
-$32.30M(+46.9%)
-$193.60M(-82.5%)
Sep 2006
-
-$60.80M(-9.5%)
-$106.10M(-33.3%)
Jun 2006
-
-$55.50M(-23.3%)
-$79.60M(-339.8%)
Mar 2006
-
-$45.00M(-181.5%)
-$18.10M(-162.4%)
Dec 2005
$29.00M(+241.5%)
$55.20M(+260.9%)
$29.00M(+164.2%)
Sep 2005
-
-$34.30M(-671.7%)
-$45.20M(+27.6%)
Jun 2005
-
$6.00M(+185.7%)
-$62.40M(+30.7%)
Mar 2005
-
$2.10M(+111.1%)
-$90.10M(-339.5%)
Dec 2004
-$20.50M(-36.7%)
-$19.00M(+63.1%)
-$20.50M(+26.5%)
Sep 2004
-
-$51.50M(-137.3%)
-$27.90M(-1450.0%)
Jun 2004
-
-$21.70M(-130.3%)
-$1.80M(-106.1%)
Mar 2004
-
$71.70M(+371.6%)
$29.50M(+296.7%)
Dec 2003
-$15.00M(+78.4%)
-$26.40M(-3.9%)
-$15.00M(-528.6%)
Sep 2003
-
-$25.40M(-364.6%)
$3.50M(-40.7%)
Jun 2003
-
$9.60M(-64.7%)
$5.90M(+118.6%)
Mar 2003
-
$27.20M(+444.3%)
-$31.80M(+54.2%)
Dec 2002
-$69.50M(+10.9%)
-$7.90M(+65.7%)
-$69.50M(+2.8%)
Sep 2002
-
-$23.00M(+18.1%)
-$71.50M(+31.7%)
Jun 2002
-
-$28.10M(-167.6%)
-$104.70M(-6.4%)
Mar 2002
-
-$10.50M(-6.1%)
-$98.40M(-26.2%)
Dec 2001
-$78.00M(-110.8%)
-$9.90M(+82.4%)
-$78.00M(+14.9%)
Sep 2001
-
-$56.20M(-157.8%)
-$91.70M(-41.3%)
Jun 2001
-
-$21.80M(-320.2%)
-$64.90M(-43.9%)
Mar 2001
-
$9.90M(+141.9%)
-$45.10M(-21.9%)
Dec 2000
-$37.00M(+70.2%)
-$23.60M(+19.7%)
-$37.00M(-176.1%)
Sep 2000
-
-$29.40M(-1370.0%)
-$13.40M(-183.8%)
Jun 2000
-
-$2.00M(-111.1%)
$16.00M(-11.1%)
Mar 2000
-
$18.00M
$18.00M
Dec 1998
-$124.00M(-18.1%)
-
-
Dec 1997
-$105.00M
-
-

FAQ

  • What is Edwards Lifesciences Corporation annual cash from financing?
  • What is the all-time high annual cash from financing for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation annual cash from financing year-on-year change?
  • What is Edwards Lifesciences Corporation quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation quarterly cash from financing year-on-year change?
  • What is Edwards Lifesciences Corporation TTM cash from financing?
  • What is the all-time high TTM cash from financing for Edwards Lifesciences Corporation?
  • What is Edwards Lifesciences Corporation TTM cash from financing year-on-year change?

What is Edwards Lifesciences Corporation annual cash from financing?

The current annual cash from financing of EW is -$983.00M

What is the all-time high annual cash from financing for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high annual cash from financing is $34.90M

What is Edwards Lifesciences Corporation annual cash from financing year-on-year change?

Over the past year, EW annual cash from financing has changed by -$272.00M (-38.26%)

What is Edwards Lifesciences Corporation quarterly cash from financing?

The current quarterly cash from financing of EW is -$506.40M

What is the all-time high quarterly cash from financing for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high quarterly cash from financing is $126.80M

What is Edwards Lifesciences Corporation quarterly cash from financing year-on-year change?

Over the past year, EW quarterly cash from financing has changed by +$470.30M (+48.15%)

What is Edwards Lifesciences Corporation TTM cash from financing?

The current TTM cash from financing of EW is -$683.10M

What is the all-time high TTM cash from financing for Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation all-time high TTM cash from financing is $34.90M

What is Edwards Lifesciences Corporation TTM cash from financing year-on-year change?

Over the past year, EW TTM cash from financing has changed by +$741.70M (+52.06%)
On this page